More Evidence Backs IL-13 Blockade in Atopic Dermatitis MedPage Today, 17 Jul 2024 Dermatology > Atopy At highest dose, novel cendakimab hits primary endpoint in phase II study by Kate Kneisel, July 17, 2024 An…